Literature DB >> 25360859

Ulnar nerve transposition at the elbow under local anesthesia: a patient satisfaction study.

Pietro M Roberti del Vecchio1, Thierry Christen1, Wassim Raffoul1, Paolo Erba1.   

Abstract

BACKGROUND: Ulnar nerve decompression at the elbow traditionally requires regional or general anesthesia. We wished to assess the feasibility of performing ulnar nerve decompression and transposition at the elbow under local anesthesia.
METHODS: We examined retrospectively the charts of 50 consecutive patients having undergone ulnar nerve entrapment surgery either under general or local anesthesia. Patients were asked to estimate pain on postoperative days 1 and 7 and satisfaction was assessed at 1 year.
RESULTS: On day 1, pain was comparable among all groups. On day 7, pain scores were twice as high when transposition was performed under general anesthesia when compared with local anesthesia. Patient satisfaction was slightly increased in the local anesthesia group. These patients were significantly more willing to repeat the surgery.
CONCLUSION: Ulnar nerve decompression and transposition at the elbow can be performed under local anesthesia without added morbidity when compared with general anesthesia. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2014        PMID: 25360859     DOI: 10.1055/s-0034-1394159

Source DB:  PubMed          Journal:  J Reconstr Microsurg        ISSN: 0743-684X            Impact factor:   2.873


  2 in total

1.  Cubital Tunnel Decompression: Equivalent Outcome Scores when Procedure Performed with Local versus General Anesthetic.

Authors:  S H Ajwani; R M Unsworth; M Tseng; M Madi; A Berg; J G Warner; P R Wykes
Journal:  J Hand Microsurg       Date:  2018-12-14

2.  Open cubital and carpal tunnel release using wide-awake technique: reduction of postoperative pain.

Authors:  Sang-Woo Kang; Hye-Mi Park; Ji-Kang Park; Ho-Seung Jeong; Jung-Kwon Cha; Ban-Suk Go; Kyoung-Tae Min
Journal:  J Pain Res       Date:  2019-09-16       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.